Kineret (Anakinra) for Rheumatoid Arthritis | myRAteam

Connect with others who understand.

sign up Log in
About myRAteam
Powered By

Kineret is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to reduce the signs and symptoms and slow the progression of structural damage in adults with moderately to severely active rheumatoid arthritis who have failed to respond to one or more disease modifying antirheumatic drugs (DMARDs). Kineret is also referred to by its drug name, anakinra.

Kineret is considered a biologic DMARD. Kineret is believed to work by reducing the activity of interleukin-1 (IL-1), a molecule that contributes to inflammation and tissue damage in rheumatoid arthritis.

How do I take it?
Prescribing information states that Kineret is administered as a subcutaneous injection (under your skin) once daily.

Kineret comes in the form of a prefilled, single-use syringe.

Side effects
The FDA-approved label for Kineret lists common side effects including injection site reactions, respiratory tract infections, headache, nausea, diarrhea, joint pain, flu-like symptoms, abdominal pain, and worsening of rheumatoid arthritis.

Rare but serious side effects listed for Kineret include severe infections and allergic reactions.

For more details about this treatment, visit:

Kineret — Sobi

Anakinra (Subcutaneous Route) — Mayo Clinic

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in